Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) entered into a settlement agreement with Teva Pharmaceuticals Industries Ltd ...

Catalyst stock gains 17% as it settles Firdapse patent litigation with Teva protecting the drug's exclusivity in the United ...

In a spacious therapy room at Bethany Children's Health Center, young patients move freely without fear of falling, supported ...

It's a pioneering way to get patients to where they need to be, whether that's a hospital emergency room, an urgent care center, a laboratory for blood work, an imaging center for an x-ray, or a ...

Cabometyx is under clinical development by Exelixis and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase transition ...

The stock price of Zydus Lifesciences surged over 5 per cent in the Tuesday trading session after the drugmaker’s wholly ...

Once abandoned, these youth can face time in shelters or eventually age out of foster care, advocates and providers say.

Tebapivat is under clinical development by Agios Pharmaceuticals and currently in Phase II for Myelodysplastic Syndrome.

Day 2 in the context of mefloquine treatment means after 6–24 h. A: Adult tablet; DHA: Dihydroartemisin; P: Pediatric tablet; PQP: Piperaquine. 1992 PYR/SDX/MQT Switzerland Asia/America 0.5 1992 ...

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

The best toothpastes for adults have fluoride, according to dentists. Shop toothpaste with the ADA Seal of Acceptance from ...

Inspra (eplerenone tablets; Pfizer, Inc., New York ... There are no well controlled studies of eplerenone in pregnant females or pediatric patients. In the congestive heart failure post-myocardial ...